Literature DB >> 232324

Prolactin receptor in human mammary carcinoma.

R Di Carlo, G Muccioli.   

Abstract

The specific binding of labelled human prolactin was determined in 83 human breast carcinomas. Twenty-seven tumors (32.5%) contained specific binding for prolactin of at least 1% and were considered prolactin receptor positive. The binding was found linearly related to membrane protein concentration and specific only for lactogenic hormones. By Scatchard analysis the dissociation constant appeared similar to that observed in other target tissues, with a low binding capacity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 232324     DOI: 10.1177/030089167906500605

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  Total prolactin binding sites in human breast cancer biopsies.

Authors:  J P Peyrat; D Dewailly; J Djiane; P A Kelly; B Vandewalle; J Bonneterre; J Lefebvre
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

2.  Characterization of prolactin receptors in human breast cancer.

Authors:  J P Peyrat; J Djiane; P A Kelly; B Vandewalle; J Bonneterre; A Demaille
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

3.  Season of tumour detection influences factors predicting survival of patients with breast cancer.

Authors:  B H Mason; I M Holdaway; A W Stewart; L M Neave; R G Kay
Journal:  Breast Cancer Res Treat       Date:  1990-01       Impact factor: 4.872

4.  Prognostic significance of serum prolactin levels in advanced breast cancer.

Authors:  M Dowsett; G E McGarrick; A L Harris; R C Coombes; I E Smith; S L Jeffcoate
Journal:  Br J Cancer       Date:  1983-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.